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Barriers and facilitators to participation
in a health check for cardiometabolic
diseases in primary care: A
systematic review
Anne-Karien M de Waard1, Per E Wa¨ndell2,
Martin J Holzmann3,4, Joke C Korevaar5, Monika Hollander1,
Carl Gornitzki6, Niek J de Wit1, Franc¸ois G Schellevis5,7,
Christos Lionis8, Jens Søndergaard9, Bohumil Seifert10 and
Axel C Carlsson2,11; on behalf of the SPIMEU Research Group
Abstract
Background: Health checks for cardiometabolic diseases could play a role in the identification of persons at high risk
for disease. To improve the uptake of these health checks in primary care, we need to know what barriers and facilitators
determine participation.
Methods: We used an iterative search strategy consisting of three steps: (a) identification of key-articles; (b) systematic
literature search in PubMed, Medline and Embase based on keywords; (c) screening of titles and abstracts and subse-
quently full-text screening. We summarised the results into four categories: characteristics, attitudes, practical reasons
and healthcare provider-related factors.
Results: Thirty-nine studies were included. Attitudes such as wanting to know of cardiometabolic disease risk, feeling
responsible for, and concerns about one’s own health were facilitators for participation. Younger age, smoking, low
education and attitudes such as not wanting to be, or being, worried about the outcome, low perceived severity or
susceptibility, and negative attitude towards health checks or prevention in general were barriers. Furthermore, practical
issues such as information and the ease of access to appointments could influence participation.
Conclusion: Barriers and facilitators to participation in health checks for cardiometabolic diseases were heterogeneous.
Hence, it is not possible to develop a ‘one size fits all’ approach to maximise the uptake. For optimal implementation we
suggest a multifactorial approach adapted to the national context with special attention to people who might be more
difficult to reach. Increasing the uptake of health checks could contribute to identifying the people at risk to be able to
start preventive interventions.
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Introduction
Cardiometabolic diseases (CMDs) including cardiovas-
cular disease (CVD), diabetes and chronic kidney dis-
ease remain the number one cause of death worldwide.1
To a large extent, CMDs are caused by an unhealthy
lifestyle, with smoking, unhealthy diet and physical
inactivity as the most important risk factors.2–5 With
the increasing rates of obesity and insuﬃcient physical
activity,6 in combination with smoking and the ageing
population,7 there is an urgent need for stimulating
CMD prevention programmes. Studies have shown
that as much as 80% of CVD could be prevented or
postponed if risk factors in lifestyle and behaviour
could be eliminated.8 To be able to do this, it is neces-
sary to ﬁnd the people with risk factors in lifestyle and
behaviour. Selective prevention,9 deﬁned as the identi-
ﬁcation of people at high risk for CMD among those
without established CMD, combined with interventions
to help prevent or delay the onset of disease therefore
represents a good starting point for CMD prevention.
The ﬁrst step of selective prevention, CMD risk assess-
ment, can be done by a health check. This health check
could be organised in several ways, such as a question-
naire that can be completed on the Internet or a more
detailed health check performed by a doctor and with
(laboratory) tests. On the one hand, health checks have
not been shown to be eﬀective to reduce mortality10
and screening and lifestyle counselling in the general
population has been shown to have no eﬀect on the
development of ischaemic heart disease.11 On the
other hand, it has been shown that health checks in
primary care led to an improvement in surrogate out-
comes such as total cholesterol, blood pressure and
body mass index (BMI)12 and a health check followed
by tailored lifestyle advice led to both increased phys-
ical activity and healthier eating habits.13 Furthermore,
improved control of modiﬁable risk factors in primary
care, in patients with multiple risk factors, was shown
to decrease cardiovascular events.14
The European Society of Cardiology (ESC) guide-
line on CVD prevention (2016) recommends perform-
ing a health check for CVD risk assessment in men
above 40 years and in women above 50 years of age
at least every ﬁve years.8 Given the longstanding and
continuous relationship of patients with their general
practitioner (GP) and the presence of up to date med-
ical records,15 GPs have an unique opportunity to
identify people at high risk for CMD among people
without established CVD, and in assessing their eligi-
bility for intervention.8 Diﬀerent examples of health
checks in primary care already exist for example in
the United Kingdom (UK),16 Czech Republic17 and
in the Netherlands.18 To be able to assess individuals’
eligibility, however, it is important that people partici-
pate in health checks. The uptake of health checks in
primary care varies widely, with response rates ranging
from 1.2% for an online risk estimation19 to 84.1% for
fasting plasma glucose measurement as screening for
type 2 diabetes.20 To improve the uptake of health
checks for CMD in primary care, we need to know
what barriers and facilitators determine participation
in health checks.
Primary care seems to be a promising setting for
CMD health checks, therefore we will focus on this
setting with a broad view on barriers and facilitators
including both characteristics and reasons related with
participation. So far, reviews did not select on charac-
teristics and reasons related to participation just in pri-
mary care but in diﬀerent settings.21,22
In this study we aim to identify characteristics and
barriers and facilitators of people for participation in
health checks for CMD in a primary healthcare setting.
Methods
Data collection
We performed a systematic search and review23 within
the framework of the SPIMEU (Determinants of
sucessful implementation of selective prevention of
CMDs across Europe) project, which is a European
Commission co-funded project and aims to identify
determinants of successful implementation of selective
prevention of CMD in primary care across Europe.24
The purpose of this review was explorative and
aimed to provide a broad overview of barriers and
facilitators for participation in health checks. Since a
broad search, including all synonyms related to this
subject, yielded more than 35,000 articles, we decided
to apply a three-step method to search for articles using
an iterative method described by Zwakman et al.25
As the ﬁrst step we deﬁned the research question and
identiﬁed ﬁve key articles related to the aim of our
review (e.g. about CMD, health checks or barriers
and facilitators for participation).26–30 Step two
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consisted of a backward and forward citation search
based on these ﬁve key articles. The backward citation
search identiﬁed articles through the reference list of the
key articles, and the forward citation search identiﬁed
articles citing one of the key articles using Google
Scholar. This yielded 30 articles (the ‘golden bullets’)
which we used to identify important keywords and
index terms to build the search including ‘barriers and
facilitators’, ‘health check’, ‘cardiometabolic diseases’,
‘primary care’ and their synonyms.
Subsequently we used the search string based on the
keywords from the golden bullets to search in Medline
(Ovid), Embase (embase.com), Cinahl (Ebsco) and
PubMed. This search strategy included both free-text
and MeSH (Medical Subject Headings) terms, and was
initially created in Medline and later adapted to the
other databases with corresponding vocabularies. The
searches were conducted by two librarians at the
University Library at Karolinska Institute in March
2016. We performed a combined search for both bar-
riers and facilitators for professionals and patients. The
results regarding the professionals are reported else-
where.31 The complete search strategies are available
in Supplementary Material File 1.
In step three, all titles and abstracts were screened
according to the eligibility criteria (see below) by either
ACC, MJH or AKW using the screening program
Rayyan.32 Selected articles were assessed for eligibility
by at least two authors (PW, AKW, MJH or ACC).
If there was any uncertainty as to whether particular
articles should be included or not, they were discussed
among the four authors that did the screening to reach a
ﬁnal decision based on the eligibility criteria. Reference
lists of included articles were also searched and articles
citing the already included studies were identiﬁed
through Google Scholar searches until no new articles
were identiﬁed anymore (Figure 1). Selected articles
were assessed for inclusion based on full text by at
least two authors (PW, AKW, MJH or ACC).
Eligibility criteria
We used the following eligibility criteria:
. Thematic focus on prevention of cardiometabolic
diseases.
. Regarding adult people (18þ) without established
CMD, so all studies performed only in patients
already diagnosed with cardiovascular disease
(or taking medication for hypertension or dyslipi-
daemia), diabetes mellitus or chronic renal failure
were excluded.
. Performed in a primary care setting.
. Data on barriers and facilitators to (not) participate
in a health check.
. Health check that started with an invitation for a
health check for CMD (not hypothetical willingness
to participate or intention to attend).
. Original research (no opinion papers such as
editorials).
. Language: English, Swedish, German or Dutch.
We deﬁned a health check as the ﬁrst step in a pre-
vention programme: inviting people for a risk assess-
ment to identify people at high risk. A health check
could be part of a prevention programme which,
according to our deﬁnition, also includes the next
step: interventions to decrease the risk in people who
are identiﬁed in the health check as being at increased
risk. In this current review, we only included informa-
tion on barriers and facilitators to participation in the
health check if possible. If information was given only
about the whole prevention programme including the
intervention then we used this information.
Assessment of study quality
Our review has an explorative nature and the interven-
tion and outcome are heterogeneous. Furthermore, the
research question can be answered using diﬀerent study
designs; quantitative, qualitative and mixed-methods
studies could give insight in barriers and facilitators
for participation. To our knowledge, no speciﬁc quality
assessment instrument is available for this type or
review. Therefore, we decided to limit the quality
assessment to two criteria: (a) adequate number of par-
ticipants: at least 100 participants and (b) control group
comparison: studies directly comparing participants
with non-participants. We used these criteria separately
to see whether the identiﬁed barriers and facilitators
changed when only good quality studies were con-
sidered compared to all studies.
Data analysis
Data extraction from the articles was performed by
AKW. The identiﬁed papers included were heteroge-
neous in design (qualitative and quantitative), in popu-
lation (from diﬀerent contexts) and in facilitators and
barriers described. We therefore decided to use a more
narrative synthesis approach which has been used in
previous research.21,22
To structure the data we divided the results into four
diﬀerent themes: (a) personal characteristics; (b) atti-
tude towards the outcome of health checks and preven-
tion in general; (c) practical issues; and (d) barriers and
facilitators for people related with the healthcare pro-
vider. Part of this structure was derived from the study
of Burgess et al.33 and adapted based on the results
from the articles included in our review.
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We then categorised factors into (a) barriers;
(b) facilitators; or (c) neutral, the latter meaning that
the factor was studied, but was not identiﬁed in the
study as a barrier or facilitator. To target the most
commonly reported ﬁndings in the articles, we decided
to pay attention in the text to factors only reported in
more than 10 articles and which were identiﬁed as a
barrier or facilitator in at least two-thirds (67%) of
these articles.
Since the studies reported their ﬁndings in a diﬀerent
manner, we used the following criteria to be able to
report the results in this review in a uniform way. In
the studies with a direct comparison between partici-
pants and non-participants, factors which signiﬁcantly
diﬀered between these groups were included in the
tables. If a multivariable analysis was performed then
the results of this analysis were used. If no signiﬁcance
level was reported, we included the factors with an abso-
lute diﬀerence between the group of attenders and non-
attenders of 5% or more. If this was not reached, we
described the factor as neutral. In studies which only
described one group, either participants or non-partici-
pants, the factors which were indicated as facilitators or
barriers in 5% or more of the studied population were
reported. We chose this low percentage because we did
not want to miss a potential barrier or facilitator.
Some health checks consisted of several steps: for
example, an online health risk assessment as the ﬁrst
step and a complete risk assessment as the second
step.20 We chose to report the barriers and facilitators
for both these steps, since they are both part of the
health check.
Articles identified through database
searching
(n = 10,566 )
Articles after duplicates removed
(n = 6,683 )
Articles excluded
(n = 6,567)
Articles screened
(n = 6,683 )
Full-text articles assessed
for eligibility
(n = 116 )
Articles included in
synthesis patients
(n = 39)
Articles included in synthesis
professionals
(n = 28)
Articles identified through
forwards and backwards
search (n = 14)
Full-text articles excluded (n = 63)
Articles included in
synthesis
(n = 67 (53+14))
Not about facilitators/ barriers for high risk screening n = 28
Lifestyle intervention n = 12
No full text n = 5
Double n = 3
No actual health check performed n = 3
Data from same dataset n = 1
Patients with disease n = 1
Not in primary care n = 2
No original research n = 8
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Figure 1. Flow-chart of studies.
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Results
Study selection and study characteristics
In total, the search identiﬁed 6683 unique articles of
which titles and abstracts were screened.
After screening for eligibility and quality, 40 articles
remained. Two articles described the results based on
the same dataset.34,35 We included only one of the two
studies34 which directly compared non-attenders with
attenders. The ﬂowchart is shown in Figure 1 and the
characteristics of the 39 included studies are sum-
marised in Tables 1–3. The included articles were pub-
lished between 1988–2016. Twenty-six studies (67%)
were conducted in the United Kingdom (UK), of
Table 1. Characteristics of studies describing attenders of health checks of cardiometabolic diseases in primary care.
Year First author
Country,
programme
Number of
participants (P)
Inclusion (in) and
exclusion (ex) Method
62 1991 Norman UK P: 159 In: age 30–50 years Questionnaire about views
health check and way of
invitation
Semi-structured interview
(n¼ 11)
46 1994 Ochera UK P: 1712 In: age 30–65 years, part had
health check <12 months,
part randomly selected
Ex: patients who had moved
or died
Registry data and
questionnaire
67 2010 Harkins UK, HaHP P: 13 In: age 45–60 years,
registered with a GP,
socio-economically
disadvantaged people
who attended follow-up
after 6 months
Ex: history of heart disease
Focus group discussions
70 2012 Hardy UK, PhyHWell P: 5 In: age: 25, 47, 48, 52, 76
years
Severe mental illness (bipolar
disorder, schizophrenia)
Interview
64 2014 Baker UK, NHS health
check
P: 1011 In: age 40–74 years Survey with quantitative and
qualitative (open-ended)
questions
29 2015 Ismail UK, NHS health
check
P: 45 baseline,
38 follow-up
In: age 40–74 years Semi-structured qualitative
interviews þ 1 year follow
up interview
36 2015 Ligthart The Netherlands,
pre-DIVA trial
P: 15 In: age 76–82 years
Ex: dementia or conditions
likely to hinder successful
follow-up
Semi-structured interviews
65 2015 Riley UK, NHS health
check
P: 28 In: age 40–74 years
Patients who attended
<6 months
Ex: existing CVD
Semi-structured interviews
68 2015 Zhong China, Dutch-
Chinese
prevention
consultation
Unknown In: age>35 years Questionnaire
49 2016 Robson UK, NHS health
check
P: 214295
(2009–2012)
In: age 40–74 years
Ex: pre-existing vascular
disease
Registry data
CVD: cardiovascular disease; GP: general practitioner; HaHP: Have a Heart Paisley; NHS: National Health Service; pre-DIVA: prevention of dementia
by intensive vascular care; UK: United Kingdom.
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Table 3. Characteristics of studies describing attenders compared to non-attenders of health checks of cardiometabolic diseases in
primary care.
Year First author
Country,
programme
Number of
participants (P),
non-participants (NP)
Inclusion (in) and
exclusion (ex) Method
38 1988 Pill (comparison) UK P: 216 NP: 259 In: age 20–45 years Questionnaire using
semi-structured
interview
48 1990 Waller UK P: 963, NP: 495 In: age 35–64 years Medical record audit and
questionnaire
39 1993 Jones UK P: 2,402, NP: 98 In: age 25–55 years, patients
with and without a history
of CHD.
Questionnaire and health
data
66 1993 Norman UK P/NP: 150 In: middle aged Health belief question-
naires before invitation
40 1993 Thorogood UK P: 2205, NP: 473 In: age 35–64 years, also
patients with angina and MI
included
Postal health belief
questionnaire before
invitation to health
check
55 1994 Davies UK
British Family
Heart Study
P: 2315 NP:141 Age 40–59 years Questionnaire
41 1994 Griffiths UK P: 113, NP: 137 In: age>16 years Questionnaire
34 1995 Christensen Denmark P: 1272, NP: 423 In: age 40–49 years, men Questionnaire
42 1997 Weinehall Sweden,
Va¨sterbotten
program
P: 14,188 NP: 10,682 In: age 30, 40, 50 or 60 years Registry data
43 2004 Wall Sweden,
Ockelbo
project
P: 237, NP: 67 In: age 35 or 40 years Questionnaire or tele-
phone interview (with
non responders
questionnaire)
44 2009 Dalsgaard Denmark,
ADDITION
study
P: 879, NP: 1100 In: age 40–69 years with high-
risk score
Ex: known diabetes
Questionnaireþ registry
data
52 2010 Marteau UK, DICISION
trial
P: 721, NP: 551 In: age 40–69 years, at risk for
diabetes (risk score prac-
tice registers)
Many were obese or used
anti-hypertensive drugs
Ex: known diabetes
Questionnaire (willingness
to change lifestyle)
(continued)
Table 2. Characteristics of studies describing non-attenders of health checks of cardiometabolic diseases in primary care.
Year First author
Country,
programme
Number of
non-participants
(NP)
Inclusion (in) and
exclusion (ex) Method
58 1988 Pill (The views) UK NP: 259 In: age 20–45 years Semi-structured interview
59 2004 study
1991
Nielsen Denmark NP: 18 In: age 30–50 years Guided qualitative interview
60 2015 Ellis UK, NHS
health check
NP: 41 In: age 40–74 years Semi-structured interviews
NHS: National Health Service; NP: non-participant; UK: United Kingdom.
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Table 3. Continued
Year First author
Country,
programme
Number of
participants (P),
non-participants (NP)
Inclusion (in) and
exclusion (ex) Method
50 2011 Dalton UK, NHS
health check
P: 2370, NP: 2924 In: age 35–74 years with
>20% 10-year risk on
CVD (GP records) incl.
people with hypertension
or using statins
Ex: CVD (CHD, stroke/TIA)
or diabetes
Electronic medical record
69 2012 Eborall UK, MY-WAIST P: 13 NP: 84 In: age 40–70 years
(30–70 South Asian and
African-Caribbean origin)
Semi-structured inter-
views or reply slip with
open-ended questions
20 2012 Klijs The Netherlands P: 4457, NP: 848 In: age 40–74 years, self-
measured waist circumfer-
ence 80 cm (women)
84 cm (men)
Ex: known diabetes
Registry data
56 2011 Lambert UK, deadly
trio-programme
P: 5871,
NP: 18,295
In: age >40 years, men from
Birmingham inner city
Ex: already in a disease
register
Routine data
37 2012 Norberg Sweden,
Va¨sterbotten
P: 96,560
observations
NP: 61,622
observations
In: 40th, 50th, and 60th
birthdays, all inhabitants
Registry data
19 2013 Van der Meer The Netherlands P: 617
NP: 142
In: age 45–70 years Registry data,
questionnaire
33 2014 Burgess UK, NHS
health check
P: 17, NP: 10 In: age 40–74 years, invited
for NHS health check
Ex: already in care-path, did
not receive invitation for
health check
Semi-structured
interviews
47 2014 Hoebel Germany,
GEDA study
P: 13,328
NP: 13,227
In: age >35 years, respond-
ents with statutory health
insurance
GEDA¼ national tele-
phone health interview
survey
51 2015 Attwood UK, NHS P: 373, NP: 1007 In: age 40–74 years Registry data
53 2015 Groenenberg
(Response)
The Netherlands Step 1 HRA
P: 308, NP: 440
Step 2 Prev. c.
P: 123, NP: 84
In: age 45–70 years (35 for
Hindustani and
Surinamese)
Electronic medical record
61 2015 Jenkinson UK, NHS
health check
P: 17, NP: 10 In: age 40–74 years, invited
for NHS health check
Semi-structured
interviews
54 2014 Krska UK, NHS
health check
P: 434, NP: 210 In: age 40–74 years, people
with estimated risk on
CVD> 20% from medical
records
Cross-sectional postal
survey
45 2016 Groenenberg
(Determinants)
The Netherlands HRA
P: 696,
NP: 196
In: age 45–70 years and low
SES
Questionnaire
57 2016 Lang UK P: 2339
NP: 3127
In: age 50–74 years, no CVD
diagnosis
Primary care electronic
health records
CHD: coronary heart disease; CVD: cardiovascular disease; GEDA: German Health Update; HRA: health risk assessment; MI: myocardial infarction;
NHS: National Health Service; NP: non-participant; P: participant; Prev c.: Prevention consultation; SES: socio-economic status; TIA: Transient ischemic
attack; UK: United Kingdom.
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which 10 reported barriers and facilitators about the
National Health Service (NHS) health check, which is
a health check for people aged 40–74 years in the UK.16
The other studies were from the Netherlands (ﬁve),
Denmark (three), Sweden (three), China (one) and
Germany (one).
Almost all studies included people in the age range
between 30–75 years, except for one study from the
Netherlands which focused on elderly people between
76–82 years of age.36 Attendance rates for health checks
ranged from 1.2%19 to 84.1%.20 Quantitative methods
for data collection were used in 27 studies, (e.g. ques-
tionnaire and registry data), qualitative methods were
used in 11 studies (e.g. focus groups and semi-struc-
tured interviews) and one study used both quantitative
and qualitative methods for data collection.
Barriers and facilitators
The factors related to participation (facilitators), non-
participation (barriers) and neutral factors are sum-
marised in Figure 2, more detailed results can be
found in Supplementary Material Files 2(a) and (b).
Personal characteristics. Socio-economic status (SES),
age, social life, smoking status, and receiving medical
Characteristics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 39
SES
Age
Smoking status
Sex
Medical care
Social life
Ethnicity
Family history of CMD
Weight
Alcohol consumption
History of, or actual disease
Risk factors for CVD
Lifestyle
Other
Attitudes
Expectations about outcome
Responsibility for / importance health
Perceived severity  / susceptibility
Attitude towards prevention
Practical reasons
Way of invitation / information
(Lack of) time
Appointment
Accessibility
Other priorities
Duration of the program
Costs
Healthcare provider
Experience GP / health care
Wasting time doctor
Practice characteristics
Legend
Barrier or facilitator
Barrier or facilitator: Less than 100 participants and/or only attenders or non-attenders
Neutral
Neutral: Less than 100 participants and/or only attenders or non-attenders
Number of articles
Figure 2. Barriers and facilitators for people to participate in a health check for cardiometabolic disease (CMD).
CVD: cardiovascular disease; GP: general practitioner; SES: socioeconomic status.
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care were studied more than 10 times and were reported
in at least two-thirds of the studies as a barrier or facili-
tator (Figure 2). In total, 22 (56%) of the studies
reported about SES, of which 16 (73%) reported it as
a barrier or facilitator (Figure 2). Diﬀerent character-
istics were classiﬁed as SES: educational level, occupa-
tion, income level and ownership of a house or car.
Low educational level was reported as a barrier in
one study37 and middle or higher educational level
was a facilitator in two studies.37,38 However in eight
studies education was neither a facilitator nor a bar-
rier.19,20,39–44 Overall, low SES was reported to be
both a barrier and a facilitator,45,46 and higher SES
to be a facilitator.47
In total, 18 studies (46%) reported about age, of
which 12 (67%) reported it as a barrier or facilitator.
Higher age was a barrier in one study39 and a facilitator
in six studies,20,44,48–51 and lower age was a barrier in
four studies.37,42,50,52 In six studies, age was neither
barrier nor facilitator (Supplementary Material
File 2).19,38,40,41,53,54
Smoking status was reported in 14 studies (36%), of
which 10 (71%) reported it as barrier or facilitator.
Smoking was a barrier for participation and not smok-
ing was a facilitator in 10 studies.20,40,41,43,47–49,55–57
Smoking was a neutral factor in ﬁve studies.19,39,50,54,55
Receiving medical care was a barrier or facilitator in
11 out of 12 studies (92%). Being under medical care,
or being recently examined, were reported as a barrier
for participation in six studies.39,43,44,58–61 In contrast,
frequently consulting a doctor was described as a facili-
tator in four studies38,40,47,48,62 and as a neutral factor
in one study.19
Factors related to social life were a barrier or facili-
tator in nine out of 12 studies (36%). Being single,
unmarried or being responsible for a young child
(<5 years) or other dependants were reported as bar-
riers in four studies.37,40,41,58 Being married or cohabi-
tating, having no responsibility for young children or
dependants and strong social support were reported as
facilitators.20,34,38,47,48
Attitudes. Attitude towards the outcome of the health
check, the feeling of being responsible for one’s own
health, perceived severity and susceptibility, and atti-
tudes towards prevention in general were studied
more than 10 times and were reported in at least two-
thirds of the studies as a barrier or facilitator. Perceived
severity was deﬁned as ‘an individual’s belief about the
seriousness of the threat’ and perceived susceptibility as
‘individual’s beliefs about his or her chances of experi-
encing the threat’.63
In total 18 studies (46%) reported about the attitude
towards the outcome of the health check. Barriers were
not wanting to know CMD risk19,33,59 and being
worried about the outcome of the check and its possible
consequences.39,58–61 On the other hand, wanting
to know CMD risk,45 wanting to be reas-
sured,29,33,36,58,61,64,65 and not having fear for the out-
come36,58 were facilitators.
In total 14 studies (36%) reported about feelings of
responsibility towards one’s own health. Facilitators
for participation were: feeling responsible for one’s
own health, ﬁnding health important or believing to
be able to inﬂuence one’s health status.29,34,38,40,45,66
Factors related with susceptibility and severity of dis-
ease were reported in 13 studies (33%). Barriers for
participation were experiencing less severity or suscep-
tibility of disease or feeling healthy,33,39,43,58,60,67–69
whereas concerns about health were facilitating for par-
ticipation.64 The attitude of people towards prevention
or towards health checks was reported in 12 studies
(31%). In general a negative attitude towards
prevention or health checks was a barrier for participa-
tion,45,54,59 whereas a positive attitude was a facilita-
tor33,60,65,66,70 or a neutral factor.54
Practical reasons. The practical reasons that were studied
more than 10 times and reported as barrier or facilita-
tor in at least two-thirds of the studies were: the kind of
invitation and information provision, time constraints
and appointment related issues.
In total, 17 studies (44%) described factors related
with the kind of invitation and information for a health
check of which 14 (82%) described this as a barrier or
facilitator. Not receiving the invitation38,39,61,67,68 and
not being familiar with the health check19,33 were iden-
tiﬁed as barriers. Clear information about the health
check,29,67 an invitation by the GP or health
centre36,68 and additional eﬀort for invitation such
as an additional phone call after the invitation,45 or
the use of outreach workers,67 were identiﬁed as
facilitators.
A barrier was lack of time, including being busy
with, for example, work or family.19,33,43,45,58–61,67,69
Being retired and working ﬂexible hours were identiﬁed
as facilitators in one study.33 Diﬃculties with arranging
the appointment, for example no time slot avail-
able outside working hours,60 were identiﬁed as
barriers, whereas health checks with no appointment
needed and easy access were identiﬁed as
facilitators.62,67,68
Healthcare provider–related factors. Barriers and facilita-
tors for people related to their healthcare provider
were not often described. All factors within this cat-
egory, such as experience with the GP (ﬁve studies)
and practice characteristics (four studies), were
described less than 10 times, so less often than the min-
imum number we reported on.
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Quality assessment
In total 28 articles (72%) reported results based on
studies with more than 100 participants. These studies
were all quantitative studies. Focus on these studies
alone did not change the results within the category
of personal characteristics and factors that were identi-
ﬁed both as barriers and facilitators were comparable.
Attitudes and practical issues were less often described
in the studies with more than 100 participants. In total,
26 studies (67%) directly compared participants and
non-participants. These studies were mostly quantita-
tive studies and only including these studies did not
change the results within the category of personal char-
acteristics. Attitudes and practical issues were less
often described in studies with direct comparison of
participants and non-participants. In Figure 2 and
Supplementary Material File 2(a), the studies that
were still included after applying both the quality cri-
teria are shown in darker colours (Figure 2) and in bold
(Supplementary Material File 2(a)).
Discussion
Summary of the results
Barriers and facilitators for people to participate or not
in health checks for CMD in primary care are hetero-
geneous. Lower age, lower education, smoking and
living alone seemed to be barriers for participation
but the results were not univocal. Wanting to know
one’s CMD risk (reassurance), feeling responsible for
one’s own health and concerns about health were facili-
tators for participation, whereas not wanting to know
the risk, being worried about the outcome, feeling
healthy, or low perceived severity or susceptibility of
disease were barriers. Furthermore, practical issues
for people to participate, such as the kind of invitation
to the health check, providing suﬃcient information,
requested time investment for the participants and pos-
sibilities for easy appointment play an important role in
the acceptance. Overall, we conclude that for a good
uptake of health checks, a multifactorial approach is
necessary.
Discussion in the light of the literature
The characteristics and reasons to (or not to) partici-
pate in CVD health checks in diﬀerent settings were
previously explored in two reviews.21,22 Dryden et al.
identiﬁed several characteristics and attitudes of people
that were related to non-participation. Non-partici-
pants were, for example, more often men, had a lower
income or SES, were younger, single, smokers and had
more cardiovascular risk factors. Furthermore, they felt
less in control over their health, valued health less
strongly and were less likely to believe in the eﬃcacy
of health checks.21
Stol et al. focused more on the reasons for partici-
pation in cardiovascular health checks. They identiﬁed
a broad range of reasons for participation, which were
related to health improvement, for example, wanting to
know health status, health monitoring, for example,
reassurance and practical issues such as a convenient
location with wide opening times. On the other hand,
they also identiﬁed reasons for non-participation which
were also related to health improvement, for example,
feeling healthy and considering risk as low.
Furthermore having no faith in screening, and not
wanting to know the outcome of the health check, prac-
tical issues such as lack of time and lack of knowledge
and poor accessibility were reasons for non-participa-
tion. The reasons for (non-)participation were compar-
able to our ﬁndings which could be partly due to some
overlap of the included articles (11/39 overlapping art-
icles), although our study was focused on primary care.
We expected that we would be able to ﬁnd personal
characteristics that would be speciﬁc for participation
in a health check for CMD. From the literature we
know that people with the largest need for medical
care are the least likely to receive it, which is known
as the ‘inverse care law’.71 Furthermore, women receive
less satisfactory preventative management than men,
especially when the GP is a man.72 Also people with a
lower SES are less likely to receive preventive care.73
This was conﬁrmed by the review of Dryden et al.: the
people at higher risk for CVD were less likely to partici-
pate in a health check21 and health checks are more
likely to serve the ‘worried well’. Our review did partly
conﬁrm these results. Smoking, lower education and a
higher age seemed to hamper participation. However,
these factors were not unanimously identiﬁed as barriers.
Given the longstanding and continuous relationship
of patients with their GP and the presence of up to date
medical records,15 GPs have a unique opportunity to
identify people at high risk for CMD among people
without established CVD, and to assess their eligibility
for intervention.8 Therefore our review focused on
health checks performed in primary care. In practice,
however, it is not necessarily the GP him/herself that
performs all tasks in the health check. For example, in
the Va¨sterbotten programme people were invited to
their primary healthcare centre, but the district nurse
played a crucial role in the actual execution of the tasks
in the health check.37 Also in the NHS Health Check
the programme is largely delivered by nurses.74
Strengths and limitations
A strength of our study is that we were able to identify
multiple articles on the subject using a rigorous search,
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including a backward and forward citation search until
no further studies were identiﬁed. We believe that this
scrutiny was suﬃcient and that no relevant articles were
missed. Furthermore, we were able to collect multiple
articles regarding health checks focused speciﬁcally on
the situation in primary care and general practice. This
review gives a broad overview of diﬀerent categories of
barriers and facilitators for participation, including a
clear overview about the factors that have been studied
and have been most frequently identiﬁed as a facilitator
or a barrier.
The studies that we included in this review were very
heterogeneous as well as the outcome measure ‘barriers
and facilitators’. We ended up with a broad range of
results which were diﬃcult to quantify, count or sum-
marise. Therefore, we decided to only report the factors
that were studied more than 10 times and reported bar-
riers or facilitators inmore than two-thirds of the studies.
Furthermore, we decided to include factors that were
signiﬁcant, or if no signiﬁcance level was reported, we
included the factors with an absolute diﬀerence between
the group of attenders and non-attenders of 5%ormore.
We do realise that this is not optimal, since signiﬁcance
also relates to the power of the study, and not merely
with the strength of the eﬀect. However, in this way we
were able to use a consistent method for data extraction
from the mix of qualitative and quantitative studies that
we included in the review. These were both pragmatic
decisions, and other options for reporting could also be
considered. However, since the results were diverse and
we did not ﬁnd factors that were consistently identiﬁed as
a barrier or a facilitator, we expect that the results will
not change drastically when other methods for describ-
ing the results would have been applied.
Our review had a descriptive aim, which was to pro-
vide an overview about barriers and facilitators.
Therefore we did not want to narrow down the
described intervention and outcome, as is usually
done in systematic reviews, for example when using a
PICO (Patient, Intervention, Comparison, Outcome)
method to describe a study. Methodologically, we
were not able to ﬁnd a validated instrument to assess
the risk of bias or study quality for the studies included
in this review. As we have noted, the studies were very
heterogeneous and each study reported multiple out-
comes in both quantitative and qualitative ways. We
applied two criteria to the studies which, in our view,
selected the studies with more robust results. We
acknowledge that individual studies that we included
have several types of bias, and that the bias of each
included study might inﬂuence the validity of reported
barriers and facilitators. However, we believe that if a
barrier of facilitator is frequently reported, and
reported in studies which included more participants,
the likelihood of it being valid is greater.
Most of the studies in our review (26 out of 39 stu-
dies in total) were from the UK. In the UK, the GP has
a strong position in the healthcare system, including a
gatekeeper role.75 The other studies were mainly from
the Netherlands, and Denmark in which the GP also
has a strong position, and primary healthcare is mostly
reimbursed for the patient. One study from Denmark
showed that the attendance rate for a health check was
much higher when it was oﬀered for free compared with
costs of around US$40.35 Overall, costs did not seem to
be an important barrier for participation in the studies
included in this review, which may be due to the fact
that most studies reported on the NHS Health Check,
which is fully reimbursed by the government for the
patient.
Three studies were conducted in Sweden, where the
GP has a somewhat weaker position. Therefore, our
results may not be generalisable to other, especially
non-Western countries with diﬀerent (primary) health-
care systems and a less strong position of the GP.
Furthermore, it may be less generalisable to countries
where people have to pay for the health check, how-
ever, based on our review it is not possible to draw ﬁrm
conclusions about this.
Clinical impact of this study
The overview of barriers and facilitators in this system-
atic review could be used for future development of
selective prevention programmes for CMD in primary
care. To improve uptake, attention could be paid to
diﬀerent aspects, as described in this review such as
personal characteristics, attitude and practical aspects.
First of all, special attention could be paid to people
who are less motivated to participate, such as smokers,
younger people and people with a lower level of educa-
tion. Secondly, uptake of health checks might be
improved by providing good information to the
people about the aims and beneﬁts of the health
check, and making them aware of their possible risk
to develop disease. Third the organisation of the
health check could be performed in such a way that
makes it as easy as possible for people to participate.
For example, a clear invitation that actually reaches the
people, a location that is easy to reach and easy access
to appointments. By improving the uptake for health
checks, especially the people at high risk, interventions
could be started to decrease their risk.
Since healthcare systems diﬀer between countries,
and the organisation of health checks such as inviting
people usually takes place on a local level, we suggest
the adaptation of the planning of the health check to
the national situation and the actual implementation to
the local situation.
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Conclusion
The barriers and facilitators for people to participate in
health checks for CMD are very heterogeneous. Hence,
it is not possible to develop a ‘one size ﬁts all’ approach
for CMD health checks. Personal characteristics, prac-
tical reasons and attitudes of people towards preven-
tion and health checks should be taken into account to
improve the uptake of health checks for CMD in pri-
mary care. For the development and implementation of
CMD health checks, we suggest a multifactorial
approach and take into account both the national
and local context. To increase uptake for health
checks, special attention should be paid to groups of
people that might be harder to reach, such as those with
low SES, smokers and people with a negative attitude
towards health checks and prevention. Increasing the
uptake of health checks could contribute to identifying
the people who are at risk for CMD to be able to start
interventions to decrease their risk.
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